Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Neuropsychological, Neuropsychiatric, and Quality of Life Issues in DBS for Dystonia

Identifieur interne : 000498 ( PascalFrancis/Corpus ); précédent : 000497; suivant : 000499

Neuropsychological, Neuropsychiatric, and Quality of Life Issues in DBS for Dystonia

Auteurs : Marjan Jahanshahi ; Virginie Czernecki ; Mateusz Zurowski

Source :

RBID : Pascal:11-0356325

Descripteurs français

English descriptors

Abstract

We review the impact of dystonia and its surgical treatment with deep brain stimulation (DBS) on cognitive function, psychiatric morbidity, and health-related quality of life. The current evidence suggests that globus pallidus internus (GPi) DBS does not cause cognitive decline in primary dystonia. However, we recommend general preoperative screening of cognition in patients with dystonia to evaluate baseline cognitive status and monitor for possible postoperative changes. Patients with mild to moderate depression appear to do well postoperatively ; however, there are scant data about those with severe depression. This is particularly problematic given reports of postoperative suicide. Patients with tardive dystonia seem to do well post-GPi DBS despite often having a history of depression or even having active severe depression. We make recommendations for screening and basic management strategies of patients identified as having a major psychiatric illness pre- or postoperatively. Quality of life in dystonia patients quantified by generic measures such as the SF36 showed improvement in both mental and physical categories following DBS surgery.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0885-3185
A03   1    @0 Mov. disord.
A05       @2 26
A06       @2 7 @3 SUP
A08 01  1  ENG  @1 Neuropsychological, Neuropsychiatric, and Quality of Life Issues in DBS for Dystonia
A09 01  1  ENG  @1 Deep Brain Stimulation for Dystonia: The State of the Art
A11 01  1    @1 JAHANSHAHI (Marjan)
A11 02  1    @1 CZERNECKI (Virginie)
A11 03  1    @1 ZUROWSKI (Mateusz)
A12 01  1    @1 MORO (Elena) @9 ed.
A12 02  1    @1 ALBANESE (Alberto) @9 ed.
A12 03  1    @1 HARIZ (Marwan I.) @9 ed.
A12 04  1    @1 KRAUSS (Joachim K.) @9 ed.
A12 05  1    @1 VERHAGEN METMAN (Leo) @9 ed.
A12 06  1    @1 VIDAILHET (Marie) @9 ed.
A14 01      @1 UCL Institute of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square @2 London @3 GBR @Z 1 aut.
A14 02      @1 Inserm CRICM U975, Department of Neurology, Groupe Hospitalier Pitié-Salpêtriére @2 Paris @3 FRA @Z 2 aut.
A14 03      @1 Department of Psychiatry, Toronto Western Hospital, University of Toronto @2 Toronto @3 CAN @Z 3 aut.
A15 01      @1 Movement Disorders Center, Division of Neurology, Toronto Western hospital, University of Toronto, UHN @2 Toronto, Ontario @3 CAN @Z 1 aut.
A15 02      @1 Istituto Neurologico Carlo Besta and Università Cattolica @2 Milano @3 ITA @Z 2 aut.
A15 03      @1 Department of Neurological Sciences, Rush University Medical Center @2 Chicago, Illinois @3 USA
A15 04      @1 Hôpital de la Salpetrière, Fédération de Neurologie, CRICM UPMC/INSERM UMR-S 975, UPMC/CNRS UMR 7225 @2 Paris @3 FRA @Z 5 aut. @Z 6 aut.
A15 05      @1 Unit of Functional Neurosurgery, UCL Institute of Neurology, Queen Square @2 London @3 GBR @Z 3 aut.
A15 06      @1 Department of Neurosurgery, Medical University, MHH @2 Hannover @3 DEU @Z 4 aut.
A20       @2 S68-S83
A21       @1 2011
A23 01      @0 ENG
A43 01      @1 INIST @2 20953 @5 354000190458070070
A44       @0 0000 @1 © 2011 INIST-CNRS. All rights reserved.
A45       @0 78 ref.
A47 01  1    @0 11-0356325
A60       @1 P
A61       @0 A
A64 01  1    @0 Movement disorders
A66 01      @0 USA
C01 01    ENG  @0 We review the impact of dystonia and its surgical treatment with deep brain stimulation (DBS) on cognitive function, psychiatric morbidity, and health-related quality of life. The current evidence suggests that globus pallidus internus (GPi) DBS does not cause cognitive decline in primary dystonia. However, we recommend general preoperative screening of cognition in patients with dystonia to evaluate baseline cognitive status and monitor for possible postoperative changes. Patients with mild to moderate depression appear to do well postoperatively ; however, there are scant data about those with severe depression. This is particularly problematic given reports of postoperative suicide. Patients with tardive dystonia seem to do well post-GPi DBS despite often having a history of depression or even having active severe depression. We make recommendations for screening and basic management strategies of patients identified as having a major psychiatric illness pre- or postoperatively. Quality of life in dystonia patients quantified by generic measures such as the SF36 showed improvement in both mental and physical categories following DBS surgery.
C02 01  X    @0 002B17
C02 02  X    @0 002B17H
C03 01  X  FRE  @0 Dystonie @5 01
C03 01  X  ENG  @0 Dystonia @5 01
C03 01  X  SPA  @0 Distonía @5 01
C03 02  X  FRE  @0 Pathologie du système nerveux @5 02
C03 02  X  ENG  @0 Nervous system diseases @5 02
C03 02  X  SPA  @0 Sistema nervioso patología @5 02
C03 03  X  FRE  @0 Qualité de vie @5 09
C03 03  X  ENG  @0 Quality of life @5 09
C03 03  X  SPA  @0 Calidad vida @5 09
C03 04  X  FRE  @0 Cognition @5 10
C03 04  X  ENG  @0 Cognition @5 10
C03 04  X  SPA  @0 Cognición @5 10
C03 05  X  FRE  @0 Chirurgie @5 11
C03 05  X  ENG  @0 Surgery @5 11
C03 05  X  SPA  @0 Cirugía @5 11
C07 01  X  FRE  @0 Syndrome extrapyramidal @5 37
C07 01  X  ENG  @0 Extrapyramidal syndrome @5 37
C07 01  X  SPA  @0 Extrapiramidal síndrome @5 37
C07 02  X  FRE  @0 Mouvement involontaire @5 38
C07 02  X  ENG  @0 Involuntary movement @5 38
C07 02  X  SPA  @0 Movimiento involuntario @5 38
C07 03  X  FRE  @0 Pathologie du muscle strié @5 39
C07 03  X  ENG  @0 Striated muscle disease @5 39
C07 03  X  SPA  @0 Músculo estriado patología @5 39
C07 04  X  FRE  @0 Trouble neurologique @5 41
C07 04  X  ENG  @0 Neurological disorder @5 41
C07 04  X  SPA  @0 Trastorno neurológico @5 41
C07 05  X  FRE  @0 Pathologie de l'encéphale @5 42
C07 05  X  ENG  @0 Cerebral disorder @5 42
C07 05  X  SPA  @0 Encéfalo patología @5 42
C07 06  X  FRE  @0 Pathologie du système nerveux central @5 43
C07 06  X  ENG  @0 Central nervous system disease @5 43
C07 06  X  SPA  @0 Sistema nervosio central patología @5 43
N21       @1 241
N44 01      @1 OTO
N82       @1 OTO

Format Inist (serveur)

NO : PASCAL 11-0356325 INIST
ET : Neuropsychological, Neuropsychiatric, and Quality of Life Issues in DBS for Dystonia
AU : JAHANSHAHI (Marjan); CZERNECKI (Virginie); ZUROWSKI (Mateusz); MORO (Elena); ALBANESE (Alberto); HARIZ (Marwan I.); KRAUSS (Joachim K.); VERHAGEN METMAN (Leo); VIDAILHET (Marie)
AF : UCL Institute of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square/London/Royaume-Uni (1 aut.); Inserm CRICM U975, Department of Neurology, Groupe Hospitalier Pitié-Salpêtriére/Paris/France (2 aut.); Department of Psychiatry, Toronto Western Hospital, University of Toronto/Toronto/Canada (3 aut.); Movement Disorders Center, Division of Neurology, Toronto Western hospital, University of Toronto, UHN/Toronto, Ontario/Canada (1 aut.); Istituto Neurologico Carlo Besta and Università Cattolica/Milano/Italie (2 aut.); Department of Neurological Sciences, Rush University Medical Center/Chicago, Illinois/Etats-Unis; Hôpital de la Salpetrière, Fédération de Neurologie, CRICM UPMC/INSERM UMR-S 975, UPMC/CNRS UMR 7225/Paris/France (5 aut., 6 aut.); Unit of Functional Neurosurgery, UCL Institute of Neurology, Queen Square/London/Royaume-Uni (3 aut.); Department of Neurosurgery, Medical University, MHH/Hannover/Allemagne (4 aut.)
DT : Publication en série; Niveau analytique
SO : Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2011; Vol. 26; No. 7 SUP; S68-S83; Bibl. 78 ref.
LA : Anglais
EA : We review the impact of dystonia and its surgical treatment with deep brain stimulation (DBS) on cognitive function, psychiatric morbidity, and health-related quality of life. The current evidence suggests that globus pallidus internus (GPi) DBS does not cause cognitive decline in primary dystonia. However, we recommend general preoperative screening of cognition in patients with dystonia to evaluate baseline cognitive status and monitor for possible postoperative changes. Patients with mild to moderate depression appear to do well postoperatively ; however, there are scant data about those with severe depression. This is particularly problematic given reports of postoperative suicide. Patients with tardive dystonia seem to do well post-GPi DBS despite often having a history of depression or even having active severe depression. We make recommendations for screening and basic management strategies of patients identified as having a major psychiatric illness pre- or postoperatively. Quality of life in dystonia patients quantified by generic measures such as the SF36 showed improvement in both mental and physical categories following DBS surgery.
CC : 002B17; 002B17H
FD : Dystonie; Pathologie du système nerveux; Qualité de vie; Cognition; Chirurgie
FG : Syndrome extrapyramidal; Mouvement involontaire; Pathologie du muscle strié; Trouble neurologique; Pathologie de l'encéphale; Pathologie du système nerveux central
ED : Dystonia; Nervous system diseases; Quality of life; Cognition; Surgery
EG : Extrapyramidal syndrome; Involuntary movement; Striated muscle disease; Neurological disorder; Cerebral disorder; Central nervous system disease
SD : Distonía; Sistema nervioso patología; Calidad vida; Cognición; Cirugía
LO : INIST-20953.354000190458070070
ID : 11-0356325

Links to Exploration step

Pascal:11-0356325

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Neuropsychological, Neuropsychiatric, and Quality of Life Issues in DBS for Dystonia</title>
<author>
<name sortKey="Jahanshahi, Marjan" sort="Jahanshahi, Marjan" uniqKey="Jahanshahi M" first="Marjan" last="Jahanshahi">Marjan Jahanshahi</name>
<affiliation>
<inist:fA14 i1="01">
<s1>UCL Institute of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Czernecki, Virginie" sort="Czernecki, Virginie" uniqKey="Czernecki V" first="Virginie" last="Czernecki">Virginie Czernecki</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Inserm CRICM U975, Department of Neurology, Groupe Hospitalier Pitié-Salpêtriére</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Zurowski, Mateusz" sort="Zurowski, Mateusz" uniqKey="Zurowski M" first="Mateusz" last="Zurowski">Mateusz Zurowski</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Department of Psychiatry, Toronto Western Hospital, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">11-0356325</idno>
<date when="2011">2011</date>
<idno type="stanalyst">PASCAL 11-0356325 INIST</idno>
<idno type="RBID">Pascal:11-0356325</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000498</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Neuropsychological, Neuropsychiatric, and Quality of Life Issues in DBS for Dystonia</title>
<author>
<name sortKey="Jahanshahi, Marjan" sort="Jahanshahi, Marjan" uniqKey="Jahanshahi M" first="Marjan" last="Jahanshahi">Marjan Jahanshahi</name>
<affiliation>
<inist:fA14 i1="01">
<s1>UCL Institute of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Czernecki, Virginie" sort="Czernecki, Virginie" uniqKey="Czernecki V" first="Virginie" last="Czernecki">Virginie Czernecki</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Inserm CRICM U975, Department of Neurology, Groupe Hospitalier Pitié-Salpêtriére</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Zurowski, Mateusz" sort="Zurowski, Mateusz" uniqKey="Zurowski M" first="Mateusz" last="Zurowski">Mateusz Zurowski</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Department of Psychiatry, Toronto Western Hospital, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Cognition</term>
<term>Dystonia</term>
<term>Nervous system diseases</term>
<term>Quality of life</term>
<term>Surgery</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Dystonie</term>
<term>Pathologie du système nerveux</term>
<term>Qualité de vie</term>
<term>Cognition</term>
<term>Chirurgie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">We review the impact of dystonia and its surgical treatment with deep brain stimulation (DBS) on cognitive function, psychiatric morbidity, and health-related quality of life. The current evidence suggests that globus pallidus internus (GPi) DBS does not cause cognitive decline in primary dystonia. However, we recommend general preoperative screening of cognition in patients with dystonia to evaluate baseline cognitive status and monitor for possible postoperative changes. Patients with mild to moderate depression appear to do well postoperatively ; however, there are scant data about those with severe depression. This is particularly problematic given reports of postoperative suicide. Patients with tardive dystonia seem to do well post-GPi DBS despite often having a history of depression or even having active severe depression. We make recommendations for screening and basic management strategies of patients identified as having a major psychiatric illness pre- or postoperatively. Quality of life in dystonia patients quantified by generic measures such as the SF36 showed improvement in both mental and physical categories following DBS surgery.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0885-3185</s0>
</fA01>
<fA03 i2="1">
<s0>Mov. disord.</s0>
</fA03>
<fA05>
<s2>26</s2>
</fA05>
<fA06>
<s2>7</s2>
<s3>SUP</s3>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Neuropsychological, Neuropsychiatric, and Quality of Life Issues in DBS for Dystonia</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG">
<s1>Deep Brain Stimulation for Dystonia: The State of the Art</s1>
</fA09>
<fA11 i1="01" i2="1">
<s1>JAHANSHAHI (Marjan)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>CZERNECKI (Virginie)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>ZUROWSKI (Mateusz)</s1>
</fA11>
<fA12 i1="01" i2="1">
<s1>MORO (Elena)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="02" i2="1">
<s1>ALBANESE (Alberto)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="03" i2="1">
<s1>HARIZ (Marwan I.)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="04" i2="1">
<s1>KRAUSS (Joachim K.)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="05" i2="1">
<s1>VERHAGEN METMAN (Leo)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="06" i2="1">
<s1>VIDAILHET (Marie)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01">
<s1>UCL Institute of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Inserm CRICM U975, Department of Neurology, Groupe Hospitalier Pitié-Salpêtriére</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Department of Psychiatry, Toronto Western Hospital, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA15 i1="01">
<s1>Movement Disorders Center, Division of Neurology, Toronto Western hospital, University of Toronto, UHN</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</fA15>
<fA15 i1="02">
<s1>Istituto Neurologico Carlo Besta and Università Cattolica</s1>
<s2>Milano</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
</fA15>
<fA15 i1="03">
<s1>Department of Neurological Sciences, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
</fA15>
<fA15 i1="04">
<s1>Hôpital de la Salpetrière, Fédération de Neurologie, CRICM UPMC/INSERM UMR-S 975, UPMC/CNRS UMR 7225</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</fA15>
<fA15 i1="05">
<s1>Unit of Functional Neurosurgery, UCL Institute of Neurology, Queen Square</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
</fA15>
<fA15 i1="06">
<s1>Department of Neurosurgery, Medical University, MHH</s1>
<s2>Hannover</s2>
<s3>DEU</s3>
<sZ>4 aut.</sZ>
</fA15>
<fA20>
<s2>S68-S83</s2>
</fA20>
<fA21>
<s1>2011</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20953</s2>
<s5>354000190458070070</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2011 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>78 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>11-0356325</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Movement disorders</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>We review the impact of dystonia and its surgical treatment with deep brain stimulation (DBS) on cognitive function, psychiatric morbidity, and health-related quality of life. The current evidence suggests that globus pallidus internus (GPi) DBS does not cause cognitive decline in primary dystonia. However, we recommend general preoperative screening of cognition in patients with dystonia to evaluate baseline cognitive status and monitor for possible postoperative changes. Patients with mild to moderate depression appear to do well postoperatively ; however, there are scant data about those with severe depression. This is particularly problematic given reports of postoperative suicide. Patients with tardive dystonia seem to do well post-GPi DBS despite often having a history of depression or even having active severe depression. We make recommendations for screening and basic management strategies of patients identified as having a major psychiatric illness pre- or postoperatively. Quality of life in dystonia patients quantified by generic measures such as the SF36 showed improvement in both mental and physical categories following DBS surgery.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B17H</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Dystonie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Dystonia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Distonía</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Pathologie du système nerveux</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Qualité de vie</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Quality of life</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Calidad vida</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Cognition</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Cognition</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Cognición</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Chirurgie</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Surgery</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Cirugía</s0>
<s5>11</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Syndrome extrapyramidal</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Mouvement involontaire</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Involuntary movement</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Movimiento involuntario</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Pathologie du muscle strié</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Striated muscle disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Músculo estriado patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Trouble neurologique</s0>
<s5>41</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Neurological disorder</s0>
<s5>41</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Trastorno neurológico</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Pathologie de l'encéphale</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Pathologie du système nerveux central</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>43</s5>
</fC07>
<fN21>
<s1>241</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 11-0356325 INIST</NO>
<ET>Neuropsychological, Neuropsychiatric, and Quality of Life Issues in DBS for Dystonia</ET>
<AU>JAHANSHAHI (Marjan); CZERNECKI (Virginie); ZUROWSKI (Mateusz); MORO (Elena); ALBANESE (Alberto); HARIZ (Marwan I.); KRAUSS (Joachim K.); VERHAGEN METMAN (Leo); VIDAILHET (Marie)</AU>
<AF>UCL Institute of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square/London/Royaume-Uni (1 aut.); Inserm CRICM U975, Department of Neurology, Groupe Hospitalier Pitié-Salpêtriére/Paris/France (2 aut.); Department of Psychiatry, Toronto Western Hospital, University of Toronto/Toronto/Canada (3 aut.); Movement Disorders Center, Division of Neurology, Toronto Western hospital, University of Toronto, UHN/Toronto, Ontario/Canada (1 aut.); Istituto Neurologico Carlo Besta and Università Cattolica/Milano/Italie (2 aut.); Department of Neurological Sciences, Rush University Medical Center/Chicago, Illinois/Etats-Unis; Hôpital de la Salpetrière, Fédération de Neurologie, CRICM UPMC/INSERM UMR-S 975, UPMC/CNRS UMR 7225/Paris/France (5 aut., 6 aut.); Unit of Functional Neurosurgery, UCL Institute of Neurology, Queen Square/London/Royaume-Uni (3 aut.); Department of Neurosurgery, Medical University, MHH/Hannover/Allemagne (4 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2011; Vol. 26; No. 7 SUP; S68-S83; Bibl. 78 ref.</SO>
<LA>Anglais</LA>
<EA>We review the impact of dystonia and its surgical treatment with deep brain stimulation (DBS) on cognitive function, psychiatric morbidity, and health-related quality of life. The current evidence suggests that globus pallidus internus (GPi) DBS does not cause cognitive decline in primary dystonia. However, we recommend general preoperative screening of cognition in patients with dystonia to evaluate baseline cognitive status and monitor for possible postoperative changes. Patients with mild to moderate depression appear to do well postoperatively ; however, there are scant data about those with severe depression. This is particularly problematic given reports of postoperative suicide. Patients with tardive dystonia seem to do well post-GPi DBS despite often having a history of depression or even having active severe depression. We make recommendations for screening and basic management strategies of patients identified as having a major psychiatric illness pre- or postoperatively. Quality of life in dystonia patients quantified by generic measures such as the SF36 showed improvement in both mental and physical categories following DBS surgery.</EA>
<CC>002B17; 002B17H</CC>
<FD>Dystonie; Pathologie du système nerveux; Qualité de vie; Cognition; Chirurgie</FD>
<FG>Syndrome extrapyramidal; Mouvement involontaire; Pathologie du muscle strié; Trouble neurologique; Pathologie de l'encéphale; Pathologie du système nerveux central</FG>
<ED>Dystonia; Nervous system diseases; Quality of life; Cognition; Surgery</ED>
<EG>Extrapyramidal syndrome; Involuntary movement; Striated muscle disease; Neurological disorder; Cerebral disorder; Central nervous system disease</EG>
<SD>Distonía; Sistema nervioso patología; Calidad vida; Cognición; Cirugía</SD>
<LO>INIST-20953.354000190458070070</LO>
<ID>11-0356325</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000498 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000498 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:11-0356325
   |texte=   Neuropsychological, Neuropsychiatric, and Quality of Life Issues in DBS for Dystonia
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024